CorMedix (CRMD) EBT Margin (2013 - 2026)
CorMedix (CRMD) reported EBT Margin of 38.00% for Q2 2026, down 13.21 percentage points from 51.21% a year earlier.
Powered by 
Analysis
CorMedix (CRMD) EBT Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CorMedix's EBT Margin came in at 44.88%, up 2.34 percentage points year-over-year; for FY2025, it came in at 48.13%, up 92.58 percentage points from FY2024.
- EBT Margin has a five-year change of +11416.67 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -44.45% in FY2024, -46305.23% in FY2022 (-30875.76 pp) and -15429.47% in FY2021 (-4060.93 pp).
- The Q2 2026 figure ranks as the lowest quarterly EBT Margin since Q3 2024.
- Year over year, EBT Margin gained in three of the last four quarters, with an average year-over-year change of +467.23 percentage points.
- The high point for year-over-year EBT Margin in five years was Q2 2022 (a gain of 33286.33 percentage points); the low point was Q1 2022 (a drop of 83813.93 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 20.41% |
| 10 | CorMedix | 417.07 Mn | -222.82 Mn | 77.13 Mn | 38.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.00% |
| Mar 31, 2026 | 43.67% |
| Dec 31, 2025 | 43.89% |
| Sep 30, 2025 | 50.42% |
| Jun 30, 2025 | 51.21% |
| Mar 31, 2025 | 52.82% |
| Dec 31, 2024 | 43.14% |
| Sep 30, 2024 | -24.24% |
| Jun 30, 2024 | -1,755.51% |
| Dec 31, 2022 | -27,637.70% |
| Sep 30, 2022 | -100,538.67% |
| Jun 30, 2022 | -38,537.88% |
| Mar 31, 2022 | -91,985.18% |
| Dec 31, 2021 | -13,814.54% |
| Sep 30, 2021 | -22,498.86% |
| Jun 30, 2021 | -71,824.21% |
| Mar 31, 2021 | -8,171.25% |
| Dec 31, 2020 | -10,925.34% |
| Sep 30, 2020 | -7,096.05% |
| Jun 30, 2020 | -54,441.52% |
API Access
CorMedix EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CRMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CRMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CRMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();